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Abstract
Background: Camelids and sharks possess a unique subclass of antibodies comprised of only heavy chains. The
antigen binding fragments of these unique antibodies can be cloned and expressed as single domain antibodies
(sdAbs). The ability of these small antigen-binding molecules to refold after heating to achieve their original
structure, as well as their diminutive size, makes them attractive candidates for diagnostic assays.
Results: Here we describe the isolation of an sdAb against Staphyloccocus aureus enterotoxin B (SEB). The clone,
A3, was found to have high affinity (Kd = 75 pM) and good specificity for SEB, showing no cross reactivity to
related molecules such as Staphylococcal enterotoxin A (SEA), Staphylococcal enterotoxin D (SED), and Shiga toxin.
Most remarkably, this anti-SEB sdAb had an extremely high Tm of 85°C and an ability to refold after heating to 95°
C. The sharp Tm determined by circular dichroism, was found to contrast with the gradual decrease observed in
intrinsic fluorescence. We demonstrated the utility of this sdAb as a capture and detector molecule in Luminex
based assays providing limits of detection (LODs) of at least 64 pg/mL.
Conclusion: The anti-SEB sdAb A3 was found to have a high affinity and an extraordinarily high Tm and could still
refold to recover activity after heat denaturation. This combination of heat resilience and strong, specific binding
make this sdAb a good candidate for use in antibody-based toxin detection technologies.
Background
The “Amerithrax” anthrax attacks of 2001 focused atten-
tion on the need for rapid and robust diagnostic meth-
ods to detect biological threat agents in environmental
and clinical samples [1]. Many laboratory diagnostic
platforms (eg enzyme linked immunosorbent assays
[ELISAs], flow cytometry, and western blots) use target-
specific antibodies to detect microbial pathogens and
toxins. Antibody based assays are particularly useful for
identifying highly purified biological toxins because such
samples contain little if any nucleic acids on which poly-
merase chain reaction (PCR) assays depend [2-4]. Sim-
plified antibody-based tests (e.g. lateral flow assays) have
been developed for field analysis and are used for a wide
range of applications [5,6]. However the standard
reagent-grade antibodies used in these tests are heat
labile, meaning that they may degrade under harsh con-
ditions, limiting field applications [7,8]. Replacing these
standard antibodies with a type of immunoreagent that
is more stable could greatly simplify the logistical
demands of field-deployed biosensors.
A handful of animal species produce antibodies that
are functional but are devoid of light chains. These
heavy chain only antibodies (HcAbs) can be isolated
from members of the Camelid family and from sharks
[9,10]. The variable regions of HcAb (VHH)w h e n
expressed as recombinant fragments, often called single
domain antibodies (sdAbs), exhibit valuable characteris-
tics including small size (12-16 kDa) and the ability to
refold following heating to temperatures which normally
causes the irreversible denaturation of conventional anti-
bodies [11,12]. These properties make sdAbs attractive
candidates for the development of immunodiagnostic
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cules (caffeine and methotrexate), or toxins (botulinum,
ricin, cholera, and scorpion), and viruses (rotavirus,
HIV, Vaccinia, and Marburg) have been isolated
[11,14-20]. Of particular relevance, a sdAb has recently
been developed for the related toxin, toxic-shock syn-
drome toxin 1 (TSST-1),[21] and another for the detec-
tion of Staphylococcus aureus [22].
Staphylococcus aureus produces a number of potent
enterotoxins, of which Staphylococcal enterotoxin B
(SEB) is the most common cause of food borne poison-
ing. SEB is a single-chain polypeptide of 239 amino
acids and has a molecular mass of 28.4 kDa [23]. In
addition to SEB’s role in food poisoning, the toxin is
considered a potential biological threat agent, and is
listed as a category B select agent by the Centers for
D i s e a s eC o n t r o l .H e r ew ed e s c r i b et h ei s o l a t i o na n d
characterization of an anti-SEB single domain antibody
from an immunized llama, and demonstrate its utility
for detecting SEB in immunoassays.
Results and Discussion
Evaluation of Serum and purified anti-SEB IgG
Our goal was to generate camelid sdAbs against SEB
using a phage display library derived from the white
blood cells of a llama serially immunized with SEB tox-
oid and to detail the antigen binding properties of iso-
lated anti-SEB sdAbs. The llama (Spode) was
immunized using SEB toxoid, and the presence of anti-
SEB toxin antibodies in the plasma was verified by
ELISA (Figure 1) prior to library construction. Once we
confirmed a robust immune response towards SEB, we
isolated RNA from the llama’sw h i t eb l o o dc e l l sf o r
library construction.
In addition to confirming the presence of anti-SEB
antibodies in the llama plasma, the Immunoglobulin G
(IgG) was purified and subclasses fractionated into
conventional (IgG1) and heavy-chain only antibody
(IgG2 and IgG3) fractions using Protein G and Protein
A columns. The IgG subclasses were evaluated by fast
protein liquid chromatography (FPLC). The IgG2 was
clearly smaller than the IgG1 as seen by FPLC, and
composed of only heavy chains as observed by polya-
crylamide gel electrophoresis (PAGE) (data not shown)
confirming the lack of light chains. However, the IgG3
fraction failed to separate from IgG1, thus results
using this material are not shown. The lama polyclonal
antibody and purified conventional (IgG1) and heavy
chain only (IgG2) fractions were evaluated along with
the isolated sdAb to assess their specificity and thermal
stability. The llama polyclonal antibody was also paired
with the isolated sdAb for use in sandwich immunoas-
says for the detection of SEB. These results are dis-
cussed below.
Isolation of the anti-SEB SdAb A3
A library was developed from the peripheral blood lym-
phocytes purified from the immunized llama. This
library was estimated to have a size of ~10
6 by the num-
ber of transformants. Eleven individual clones were pla-
que purified and sequenced; all 11 were found to be
unique and full length. To isolate a SEB specific sdAb
from the phage display library we conducted 3 rounds
of panning, followed by monoclonal phage ELISA. Fol-
lowing ELISA, 11 clones were selected and sequenced;
all sequenced clones (n = 11) had identical base pair
sequences indicating that by round 3 of panning the
diversity of binders had been reduced to a single clone.
The predicted amino acid sequence, represented by
clone A3, is shown in Figure 2A. To evaluate its binding
characteristics, clone A3 was expressed as a soluble pro-
tein and purified; its size (~16 kDa) was confirmed on a
western blot (Figure 2B).
Specificity of the anti-SEB SdAb A3 and polyclonal llama
IgG
The initial studies examined the cross-reactivity of A3,
as well as both IgG1 and IgG2 subclass fractions, to a
panel of common threat agent toxins using Luminex
direct binding assays (Figure 3). We found that A3 was
specific for SEB toxin and did not cross react with other
toxin targets including super antigen relatives such as
SEA and SED. This specificity, which is also observed in
conventional monoclonal antibodies, is ideal for devel-
oping target-specific reagents for immunodiagnostics or
environmental sensing. The llama polyclonal IgG1 and
IgG2 subclass antibodies purified from the animal
demonstrated a much higher titer for SEB relative to the
other toxins, but at higher IgG concentrations they dis-
played cross reactivity towards SEA and SED, demon-
strating the rationale for using highly selective
monoclonal antibody reagents.
Thermal stability of the anti-SEB SdAb A3 and polyclonal
llama IgG
Once the specificity of the sdAb A3 had been estab-
lished we evaluated its thermal stability, comparing the
selected sdAb with anti-SEB MAb 3b2a, as well as the
llama polyclonal IgG1. First, an activity assay was uti-
lized, wherein biotinylated aliquots of sdAb A3, llama
polyclonal IgG, rabbit anti-SEB (RA-SEB) and anti-SEB
MAb 3b2a were evaluated by heating to 85°C for various
lengths of time. After cooling, their ability to bind SEB
coated microspheres was evaluated (Figure 4). Within
10 minutes of heating conventional llama antibody
(IgG1), as well as RA-SEB and MAb 3b2a, rapidly lost
80% of their binding activity and after an hour they had
lost over 95%. The binding activity of the llama heavy
chain antibody subclass IgG2 initially declined 40%
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only slowly over the remaining forty five minutes,
retaining ~30% of the initial activity. Clearly, the sdAb
A3 exhibited the best stability, decreasing slightly (20%)
upon initial heating but then residual activity remained
fairly constant, dropping again during the last 15 min-
utes to 45% of the initial activity after heating for 1
hour.
Next, we examined the effect of heating on the sec-
ondary structure of the antibodies (non-biotinylated) by
monitoring their CD spectrum during heating. The CD
spectrum shows that the sdAb A3 unfolded upon heat-
ing and then refolded when cooled (Figure 5A). A3 was
then subjected to multiple cycles of heating and cooling
(Figure 5B and 5C). By monitoring the ellipticity at 202
nm, A3 was observed to start losing secondary structure
at 80°C, with a melting point at ~85°C. After cooling
down, the sdAb was found to recover the majority of its
secondary structure. The unfolding and refolding transi-
tions occurred rapidly and at nearly the same tempera-
ture. Clone A3 has one of the highest melting points we
have observed to date for a sdAb [24-29]. To confirm
this melting point, this value was also determined using
DSC (Figure 6). This method yielded a melting point of
85°C, however under these conditions, high concentra-
tion and high maximum temperature, no refolding was
observed. To evaluate the melting temperatures of
sdAbs, including A3, we constructed a normal probabil-
ity plot (Figure 7). Points on this plot will lie along the
regression line if the data conforms to a normal distri-
bution. For 11 antibodies for which Tm has been deter-
mined (unpublished observations) the data can be seen
to fit well to a normal distribution. A3, with a Tm
above 85°C, can be seen to deviate significantly, imply-
ing that this data cannot be explained as an expected
variation in a normal distribution.
Another interesting finding was that even though the
sdAb A3 maintains its secondary structure until 80°C,
its intrinsic fluorescence decreased in a nearly linear
relationship with temperature (Figure 8A and 8B). The
decrease in fluorescence intensity can be attributed to
the decreasing hydrophobic environment of buried tryp-
tophans as well as to increased vibrational decay due to
increased motion. Fundamentally, these results indicate
Figure 1 ELISA results of direct binding of llama plasma to SEB toxin and toxoid coated wells. This data verifies the presence of SEB toxin
and toxoid binding IgG in the immunized llama plasma.
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to monitor protein folding, with the actual CD spectra
providing a more precise Tm. These results are con-
trasted by the CD and fluorescence measurements of
the llama IgG1 anti-SEB, which lost both secondary
structure and fluorescence intensity at comparable
rates (Figure 8C and 8D). More importantly, conven-
tional IgGs do not refold properly after heating,
permanently losing the bulk of their secondary struc-
ture and activity. The thermal resilience shown by the
sdAb could be extremely useful for detection systems
because sdAb molecules could be repeatedly used to
capture their target simply by serially heating and cool-
ing. Such an application would be an important contri-
bution to current bio-detection technologies as it
Figure 2 Amino acid sequence and western blot of sdAb A3. A)
Predicted amino acid sequence of the A3 anti-SEB sdAb. CDRs are
highlighted. B) Western Blot of purified sdAb A3 using anti-His-HRP
antibody. Benchmark ladder.
Figure 3 Evaluation of specificity by Luminex fluid array direct
binding assays: Bt-sdAb A3 (top panel), Bt- llama anti-SEB IgG1
(middle panel), and Bt-IgG2 (bottom panel) subclass fraction.
Result show A3 is highly specific for SEB.
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monitoring systems.
Affinity of the anti-SEB sdAb A3
The affinity constants of sdAb A3 were determined
u s i n gS P R( F i g u r e9 ) .A 3w a sf o u n dt oh a v eav e r yh i g h
affinity for SEB, Table 1. Similar results were obtained
from both the covalently immobilized A3 and the Bt-A3
bound to a NeutrAvidin coated chip, with both yielding
a KD of ~ 400 to 600 pM. When the SEB was immobi-
lized, A3 bound even more effectively, with a measured
KD of ~ 75 pM, confirming the high affinity interaction
that A3 has for SEB. The MAb 3b2a also had a very
high affinity for SEB. In fact it’s off rate was so low we
were unable to determine an accurate affinity (KD ≤ 100
pM). These high affinities explain the ability of these
immunoreagent to sensitively detect SEB as demon-
strated below.
Sandwich immunoassays for the detection of SEB using
the anti-SEB sdAb A3
The final studies utilized the sdAb A3 as either the cap-
ture molecule or the detection molecule in fluid array
sandwich immunoassays for SEB. In addition to A3, the
MAb 3b2a and the purified llama polyclonal anti-SEB
were utilized (Figure 10). SdAb A3 functioned well
when paired with MAb 3b2a in the sandwich immu-
noassay indicating that they recognize different epitopes.
When A3 was the Bt detector and MAb 3b2a the cap-
ture molecule (Figure 10 top panel) the assay could
detect as little as 64 pg/mL SEB. The reverse configura-
tion, Bt-MA3b2a detector and sdAb A3 capture (Figure
10 middle panel), was not as sensitive with a LOD of 40
ng/ml. While the llama polyclonal antibody was a poor
capture molecule, presumably due to its relatively low
titer, the Bt-llama polyclonal antibody functioned very
effectively as a Bt-labeled detector in combination with
all the captures (Figure 10 bottom panel). Limits of
detection of 64 pg/mL SEB were observed with the
sdAb A3 and llama IgG1 anti-SEB captures, while when
paired with the monoclonal it gave a signal intensity
~10-fold greater, suggesting that pair would have an
even more impressive LOD. The large differential
between the A3 and the Mab 3b2a capture molecules
when using the polyclonal detector may occur because
the polyclonal antibody favors the same epitope as the
A3. Nonetheless, the A3 sdAb provided detection limits
to 64 pg/mL as both a capture and detector molecule,
Figure 4 Evaluation of thermal stability by binding activity. SdAb A3 at 10 μg/ml and antibodies (llama anti-SEB IgG1, RA-SEB, and anti-SEB
MAb 3b2a) at 100 μg/ml were heated at 85°C. Aliquots were removed and tested. The samples were diluted 10-fold and tested for their antigen
binding ability in a Luminex direct binding assay.
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detection requirements. In addition, the thermal stability
and ability to re-fold after denaturation should give
sdAbs, such as A3, an advantage when incorporated
into biosensors for use in austere environments. For
such applications it would be advantageous to isolate a
second anti-SEB sdAb that recognized a different epi-
tope towards developing a sandwich immunoassay not
reliant on monoclonal or polyclonal conventional anti-
bodies. The selection of such sdAb from this same
library for the development of an all sdAb immunoassay
is the next goal of this research effort.
Conclusions
In conclusion, the antigen recognition capabilities of the
llama derived sdAb A3 were strong and specific for its
target, SEB. The A3 sdAb was also found to be extre-
mely heat resilient and to refold correctly following heat
denaturation. These traits make it a valuable contribu-
tion to the current biodefense and public health arsenals
of threat detection molecules. The availability of high
affinity and recyclable recognition elements, such as A3,
might also be used to increase the functional range of
biosensors in the near future.
Methods
Immunization Protocol and Serology
An adult male llama housed at Triple J Farms (Bellingham,
WA) was immunized with purified SEB toxoid (Toxin
Technologies) intramuscularly followed by three boosters
at three week intervals with 225 μg of purified SEB toxoid.
Sera was collected immediately before each inoculation
and used to monitor the total IgG response against SEB.
Three weeks after the final immunization 500 mL of
whole blood and 50 mL of plasma was collected and used
for lymphocyte isolation and serology. White blood cells
were immediately isolated from the whole blood for RNA
purification. Plasma was stored at -80°C until used. Animal
studies were approved by a separate review board through
Triple J Farms and Kent Laboratories.
Total IgG responses to SEB toxin (Sigma Aldrich) and
toxoid were measured over the course of the immuniza-
tion series by direct ELISA. Briefly, plate wells were coated
with 0.5 μg/mL of SEB toxin or toxoid overnight at 4°C.
The following morning wells were washed three times
with phosphate buffered saline (PBS) followed by addition
o f3 %n o n - f a tM i l ki nP B S( M P B S )a n dk e p ta t3 7 ° Cf o r
two hours. Afterward, wells were washed again three times
with PBS followed by coating them with diluted sera
(1:1000) for 1 hour at 37°C. The wells were again washed
three times with PBS and incubated with anti-llama IgG
(H+L) horse radish peroxidase (HRP) Conjugated (Bethyl
Laboratories) at 1:5000 for 1 hour. Finally, wells were
washed three times with PBS before the addition of
Figure 5 Evaluation of A3's thermal stability by monitoring
secondary structure by CD. A3 was heated to 85°C and then
cooled to 25°C repeatedly: A) CD spectra of A3 (blue line) and upon
heating to 85°C (1
st cycle, pink; 2
nd cycle, orange) and upon cooling
to 25°C (1
st cycle, green line; 2
nd cycle, red line). Alternatively,
secondary structure can be monitored and Tm determined by
tracking the ellipticity change at single wavelength 202 nm: B) 4 heat
cycles to 95°C, first cycle blue, second cycle green, third cycle red,
and fourth cycle black; C) 4 cooling cycles color coded as in panel B.
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read by optical density (OD) at 455 and 650 nm.
IgG antibody purification
IgG was purified from llama plasma using a two-step
process of Caprylic Acid (CA) to partially purify the IgG
followed by using MEP HyperCel hydrophobic charge
induction chromatographya sp r e v i o u s l yd e s c r i b e d
[30,31]. The IgG was separated into subclasses by a
combination of affinity chromatography on protein G
and protein A columns as described previously [32-34].
Phagemid Library Construction and Panning
White blood cells were isolated from the final post
immunization bleed using Ficoll-Plaque Plus (GE Life-
sciences), pelleted and washed with PBS, pelleted and
stored at negative 80°C in Trizol (Invitrogen) until
used for RNA extraction. RNA was extracted from Tri-
zol and converted to cDNA using Arrayscript
(Ambion) via oligo-dT primed reverse transcription.
VHH coding regions were amplified by nested PCR as
previously described [32,35]. The first round, 600 bp
amplicon, was agarose gel purified using Ultrafree-
DNA kit (Millipore) and used as the template for the
secondary PCR reaction using the nested primers
which amplify a 450 bp region and incorporate SfiI
and NotI restriction sites into the 5’ and 3’ ends,
respectively [15]. The 450 bp amplicons were agarose
gel purified as before and then digested with SfiI and
NotI. The resulting fragments were gel purified using
Ultrafree-DNA system and concentrated with the
Microcon YM-100 (Millipore). Purified DNA was
ligated, using T4 DNA Ligase, into an open M13 pha-
gemid vector, pCANTAB 5 E (GE Lifesciences). The
ligations were then desalted and electroporated into
electrocompetent XL-1 Blue Escherichia coli (Strata-
gene) and then pooled to form the library. A 10-fold
serial dilution series of the library was plated out on
Luria Broth plates containing 100 μg/mL Ampicillin
(LB amp100) and colony counts used to estimate total
library size of ~10
6 variants. Phage displayed SEB-spe-
cific VHH antibodies were isolated by phage rescue and
panning. Phages were rescued via M13K07 phagemid
purification [36]. Screened isolates were then used as
the starting point for the second round of panning,
and this process was repeated twice more for a total of
3 rounds of selective panning. Third round isolates
were plaque assayed, randomly chosen from plates, to
be screened for SEB-specific binding by ELISA. The
plate was coated overnight with 5 μg/mL SEB in PBS.
The wells were then blocked with 3% MPBS for 2 hrs
at 37°C. PEG precipitated phage from 96 individual
colonies was added to each well, and the plate was
incubated for 90 minutes at room temperature. Anti-
M13-HRP conjugate (GE Lifesciences) diluted 1:5000
in MPBS was added to each well and incubated for 90
min at room temperature. Plates were developed with
the substrate reagent pack, and the reaction was mon-
itored at OD 455 and 650 nm. Clones were ranked
based on absorbance and the top 11 chosen for
further characterization.
Figure 6 Differential Scanning Calorimetry of the sdAb A3.
Antibody melting was observed in PBS with a protein concentration
of 1.6 mg/ml. Heating rate was 1°C per minute. Melting
temperature was about 82.6°C and refolding upon cooling was not
observed.
Figure 7 The Tm of A3 deviates from a normal distribution.A
total of 12 SdAb for which the melting temperatures have been
determined are presented on a normal probability plot. The Y-axis
values are specified by the probability distribution function for an
assumed normal distribution. The straight line is a robust linear
regression of the data and all data points will be near the line if the
assumption is correct. The Tm for A3 can be seen to fit poorly.
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DNA sequences spanning the VHH portion of each of
the 11 high binders were determined by commercial
sequencing provided by MCLAB. Sequences were ampli-
fied using lacZ’ forward primer 5’-ctatgaccatgattac-
gaatttctag-3’. Sequence analysis was performed using
Geneious software (Biomatters Ltd.).
Protein Expression and Purification
A single sdAb variant, A3, was chosen for further analysis
a n dc l o n e di n t ot h ep e c a n 4 5e x p r e s s i o nv e c t o r( k i n d l y
provided by Andrew Hayhurst, Southwest Foundation for
Biomedical Research) and transformed into BL-21 Rosetta
Escherichia coli cells (Novagen). SdAb protein was overex-
pressed and purified following protocols described pre-
viously [11]. In brief, A3 was overexpressed using
Isopropyl b-D-1-thiogalactopyranoside (Fisherbrand); pro-
teins were extracted from the periplasmic compartment
by osmotic shock and purified by Immobilized Metal Ion
Affinity Chromatography (IMAC) via incubation and elu-
tion from Nickel Sepharose (GE Lifesciences) [37]. Purified
protein was stored at 4°C prior to gel filtration on a
Figure 8 Comparison of CD spectra and intrinsic fluorescence intensity of sdAb A3 to llama IgG1 taken at 5°C intervals from 25°C to
85°C. SdAb A3 a) CD spectra b) fluorescence intensity. Llama anti SEB IgG1 c) CD spectra d) fluorescence intensity. Results indicate that intrinsic
fluorescence changes fail to correlate with the sdAb’s loss of ellipticity upon heating, while intrinsic fluorescence does correlate with ellipticity for
the polyclonal IgG.
Figure 9 SPR binding profiles for sdAb A3. Panel A shows five concentrations of SEB (30, 10, 3.3, 1.1, and 0.37 nM) flowed for 3 minutes over
immobilized sdAb A3, followed by 15 minutes dissociaiton. Data shown was corrected by subtraction of interspot data and the buffer only
response. Panel B shows a similar experiment performed on a NeutrAvidin coated chip with Bt-sdAb A3 immobilized. Panel C shows sdAb A3
(30, 10, 3.3, 1.1, and 0.37 nm binding to a surface coated with SEB.
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quantified using micro-BCA assay (Pierce) following man-
ufacturer’s protocols.
Western blots were preformed to confirm the purified
protein’s size. Purified protein samples were analyzed by
SDS-PAGE on 12% Tris-Cl polyacrylamide gel by elec-
trophoresis for 37 minutes at 200 V. Following electro-
phoresis the gel was transferred to a nitrocellulose
membrane (BioRad) for 1 hour at 100 V. Membranes
were incubated overnight at 4°C with MPBS with 0.05%
Tween 20 (MPBST), followed by incubation with anti-6
× His-HRP antibody (GenScript) for 1 hour at room
temperature with shaking. The membranes were devel-
oped using Immuno-star Western C kits (Bio-Rad) fol-
lowing the manufacture’s protocols, and images were
captured on Versadoc (BioRad).
Luminex Analysis
A Luminex 100 flow analyzer was used to determine the
specificity of the isolated sdAb as well as to perform
sandwich assays for SEB. Antibodies were biotinylated
(Bt) as previously described [25] using NHS-LC-biotin
dissolved first in DMSO; a 20:1 NHS-biotin molar
excess was used. Gel filtration on a Bio-gel P10 column
was used to separate the biotin excess. Luminex micro-
spheres for direct binding assays were coated with: two
lots of SEB toxin, bovine albumin (BSA) (Sigma); Shiga
Toxin 1 (STX-1), staphylococcal enterotoxin D (SED),
staphylococcal enterotoxin A (SEA) (Toxin Technolo-
gies); Ricin, Ricinus communis Agglutinin 120 (RCA-
120) (Vector); Cholera Toxin (CTX) (Calbiochem). For
sandwich immunoassays, microspheres were coated with
the A3 sdAb, the purified polyclonal llama anti-SEB,
and a monoclonal anti SEB MAb 3b2a kindly provided
by Dr. Jill Czarnecki (Naval Medical Research Center,
Silver Spring, MD). The protocol provided by Luminex
for two-step carbodiimide coupling as previously
described [11] was utilized to coat 0.1 mL of micro-
spheres using 0.1 mg protein at a concentration of ~1
mg/mL. The protein-coated microspheres were stored at
4°C in the dark until use.
Sandwich immunoassays for SEB were performed
using A3 as both the capture molecule as well as the
biotinylated detector In addition, the monoclonal
Table 1 Result of SPR binding analysis
Capture Molecule ka
1/Ms
kd
1/s
KD
SdAb-A3 1.0 × 10
+5 6.0 × 10
-5 6.0 × 10
-10
NA-Bt-A3 7.2 × 10
+4 2.8 × 10
-5 3.9 × 10
-10
SEB 2.9 × 10
+5 2.2 × 10
-5 7.5 × 10
-11
The kinetic binding results obtained from the data shown in Figure 8. Kinetic
parameters were determined by fitting the curves using a Langmuir model.
Figure 10 SEB detection using Luminex sandwich assays. Three
different anti-SEB antibody coated bead sets plus a negative control
were used in each assay performed as described in the methods.
Top panel used Bt-sdAb-A3 (1 μg/mL), middle panel used Bt-MAb
3b2a (10 μg/mL), and bottom panel Bt-Llama anti-SEB (10 μg/mL),
respectively as the detector antibody, followed by SA-PE (5 μg/mL)
to fluorescently label the immuno-complex prior to measurement
on the Luminex 100.
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anti-SEB (Ll-anti-SEB) antibody were also tested as the
capture and detector molecule. SEB at a variety of con-
centrations was incubated with the antibody coated
microspheres for 30 minutes. Unbound SEB was
removed by filtration and the microspheres washed
twice with PBS containing 0.05% Tween-20 (PBST). The
microspheres were then incubated with biotinylated
detector antibodies: Bt-A3 (1 or 2 μg/mL), Bt-Mab 3b2a
(5 μg/mL), Bt-Ll-anti-SEB (10 μg/mL) for 30 minutes.
After washing twice the amount bound was fluores-
cently labeled by the addition of 5 μg/mL SA-PE. After
30 minutes the excess SA-PE was removed and the
microspheres resuspended in 85 μL PBST and measured
on a Luminex 100.
Thermal stability was tested using biotinylated antibo-
dies (polyclonal llama anti-SEB IgG, MAb 3b2a, and
sdAb A3 anti-SEB). The antibody samples were heated
in a thermocycler at 85°C for different times up to 60
minutes, stored at 4°C for 1 hour, and then evaluated
using a direct binding Luminex assay. Specificity of
binding of the A3 variant was evaluated by a cross-reac-
tion panel to various toxins and proteins (see above list)
coupled to microspheres via a direct binding assay. Puri-
fied A3 sdAb was allowed to bind for 30 minutes at
room temperature then the entire panel was run simul-
taneously on the Luminex.
Circular Dichroism (CD)
The melting point of the A3 sdAb was measured by cir-
cular dichroism using a Jasco J-815 CD spectropolari-
meter equipped with a PTC-423S single position peltier
temperature control system. Samples (~30 μg/mL) were
prepared by extensive dialysis versus 5 mM sodium
borate pH 7.5, or by simple dilution with that same buf-
fer. All measurements were made in a 10 mm path
length quartz cuvette with a stir bar. The data were
acquired from 245 nm to 195 nm at a scanning speed of
20 nm/min. The data pitch was 1 nm, D.I.T. 2 seconds,
band width 1 nm, temperature ramp rate of 5°C/min
over the range of 25 to 95°C. Intrinsic protein fluores-
cence intensity was also measured simultaneously using
a 345 nm filter.
Differential Scanning Calorimetry (DSC)
The melting point was also measured by DSC using a
TA Instruments NanoDSC. Antibody at a concentration
of 1.6 mg/ml in PBS was scanned at a rate of 1°C per
minute from 25°C to 120°C.
Surface Plasmon resonance (SPR) kinetics analysis
T h eS P Rk i n e t i cm e a s u r e m e n t sw e r ep e r f o r m e du s i n g
the ProteON (Bio-Rad). For testing the kinetics of the
anti-SEB sdAb A3 a variety of surfaces were prepared.
In one case a GLC chip was coated with the sdAb A3 (5
μg/mL) along with sdAb specific for other targets (none
of which bound SEB and served as negative controls for
the tests presented here). A GLC chip was also coated
with SEB (5 μg/mL), as well as other toxins which
served as negative controls. All the protein samples to
be immobilized were diluted in 10 mM acetate buffer
pH 5.0 following the standard EDC coupling chemistry
provided by the manufacturer. To ensure that biotinyla-
tion of the sdAb A3 had no affect on its activity, a Neu-
trAvidin coated chip was coated with Bt-sdAb A3. All
experiments were performed at 25°C. The binding of
the sdAb were tested by flowing 6 concentrations vary-
ing from 30 nM to 0 nM for 180 seconds over the SEB
coated chip, and then monitoring dissociation for 900
seconds. The chip was regenerated using 50 mM gly-
cine-HCl (pH 2.0) for 36 seconds, prior to any addi-
tional testing. The data were analyzed with the ProteON
Manager TM 2.1 software; binding constants were
determined using the software’s Langmuir model. Assays
for binding of SEB by the immobilized sdAb were done
in an analogous manner.
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